Sinoway Industrial Co., Ltd.

Pitavastatin Calcium 147526-32-7 Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Related Products
  • Mupirocin 12650-69-0

    Details of MupirocinOther Names: mupirocinMF: C26H44O9Place of Origin: Fujian, China (Mainland)Type: Auxiliaries and Other Medicinal Chemicals, Immune Function AgentsGrade Standard: Medicine GradeBran...

  • Atracurium Besylate 64228-81-5

    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton...

  • Ceftiofur Sodium 104010-37-9

    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ...

Basic information of Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Usage of Pitavastatin Calcium 147526-32-7

  • Pitavastatin calcium is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease.

COA of Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7

MORE_DETAIL Pitavastatin Calcium 147526-32-7

Basic information of Pitavastatin Calcium 147526-32-7

Name

Pitavastatincalcium

CAS:

147526-32-7

Molecular Formula

C50H46CaF2N2O8

Molecular Weight

880.98

Quality Standard

In-house Standard, Assay: >99.0%

Package Size

For small quantity: Double plastic bag inside, Aluminum foil bag outside

For commercial quantity: 25kg fiber drum & Aluminum tin

Brief Introduction

Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication 
class of statins, marketed in the United States under the trade name Livalo. Like other statins, it
is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis.

It has been available in Japan since 2003, and is being marketed in South Korea and in India.
[2] It is expected that pitavastatin will be approved outside Southeast Asia as well.
[3] In the US, it received FDA approval in 2009. Kowa Pharmaceuticals is the owner of the American patent to pitavastatin.


Usage of Pitavastatin Calcium 147526-32-7

  • Pitavastatin calcium is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease.

COA of Pitavastatin Calcium 147526-32-7

Pitavastatin Calcium 147526-32-7
Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//